PEZZICOLI, GAETANO
 Distribuzione geografica
Continente #
NA - Nord America 226
EU - Europa 122
AS - Asia 33
Totale 381
Nazione #
US - Stati Uniti d'America 225
SE - Svezia 36
IT - Italia 33
SG - Singapore 25
GB - Regno Unito 14
FR - Francia 9
DE - Germania 7
FI - Finlandia 7
CN - Cina 6
AT - Austria 3
LT - Lituania 3
BE - Belgio 2
CZ - Repubblica Ceca 2
CA - Canada 1
ES - Italia 1
HR - Croazia 1
HU - Ungheria 1
IN - India 1
NL - Olanda 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
UA - Ucraina 1
Totale 381
Città #
Chandler 47
Nyköping 36
New York 31
Singapore 19
Bari 15
Ashburn 12
Lawrence 10
Fairfield 9
Helsinki 7
Paris 7
Cambridge 6
Roxbury 6
Seattle 6
Woodbridge 6
Houston 5
Ann Arbor 4
Inglewood 4
London 4
Princeton 4
Des Moines 3
Munich 3
Terlizzi 3
Brighton 2
Brno 2
Brussels 2
San Diego 2
Santa Clara 2
Torino 2
Wilmington 2
Amsterdam 1
Boardman 1
Bologna 1
Bordeaux 1
Bratislava 1
Catanzaro 1
Falkenstein 1
Ferrara 1
Frankfurt am Main 1
Hounslow 1
Kilburn 1
Lahore 1
Los Angeles 1
Madrid 1
Modugno 1
Monmouth Junction 1
New Bedfont 1
Nuremberg 1
Ottawa 1
Pune 1
Redmond 1
San Mateo 1
Shanghai 1
Sopron 1
Southwark 1
Vienna 1
Wernigerode 1
Zagreb 1
Totale 289
Nome #
DLC-1 down-regulation via exosomal miR-106b-3p exchange promotes CRC metastasis by the epithelial-to-mesenchymal transition 60
Liquid Biopsy as a Tool Exploring in Real-Time Both Genomic Perturbation and Resistance to EGFR Antagonists in Colorectal Cancer 56
Large extracellular vesicles—a new frontier of liquid biopsy in oncology 53
Combination of immunotherapy and other targeted therapies in advanced cutaneous melanoma 41
Biliary tract cancers: moving from the present standards of care towards the use of immune checkpoint inhibitors 34
Adoptive T-cell immunotherapy in digestive tract malignancies: Current challenges and future perspectives 32
Playing the devil’s advocate: Should we give a second chance to mTOR inhibition in renal clear cell carcinoma? – ie strategies to revert resistance to mtor inhibitors 29
Uterine carcinosarcoma: An overview 27
Beyond ras and braf: Her2, a new actionable oncotarget in advanced colorectal cancer 25
Abstract 2012: In vitro validation of tumor-derived large extracellular vesicles isolation and characterization as suitable tool for liquid biopsy 22
A Glimpse in the Future of Malignant Mesothelioma Treatment 22
Angiogenesis in NENs, with a focus on gastroenteropancreatic NENs: from biology to current and future therapeutic implications 21
MiT translocation renal cell carcinoma: A review of the literature from molecular characterization to clinical management 10
IL-8 and its role as a potential biomarker of resistance to anti-angiogenic agents and immune checkpoint inhibitors in metastatic renal cell carcinoma 9
Clinico-pathological implications of the 2022 WHO Renal Cell Carcinoma classification 8
Sarcoidosis-like reactions in metastatic renal cell carcinoma patients treated with immune-based combinations 5
[The Treatment of Metastatic Renal Cell Carcinoma: An Update] 5
Totale 459
Categoria #
all - tutte 3.865
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.865


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010 0 0 0 0 0 0 0 0 0 6 2 2
2020/202160 2 2 6 15 6 1 0 13 2 7 2 4
2021/202246 2 0 0 2 0 3 0 2 13 2 10 12
2022/2023130 11 26 9 3 17 15 7 18 15 1 3 5
2023/202499 1 27 7 10 4 33 2 2 3 0 0 10
2024/2025114 24 5 30 42 13 0 0 0 0 0 0 0
Totale 459